GeoVax to Report 2023 Financial Results and Provide Corporate Update on February 29, 2024

February 22, 2024

https://www.globenewswire.com/news-release/2024/02/22/2833733/0/en/GeoVax-to-Report-2023-Financial-Results-and-Provide-Corporate-Update-on-February-29-2024.html

GeoVax to Host Conference Call at 4:30 PM ET

ATLANTA, GA, Feb. 22, 2024 (GLOBE NEWSWIRE) — via NewMediaWire – GeoVax Labs, Inc. (Nasdaq:GOVX), a clinical-stage biotechnology company developing immunotherapies and vaccines against cancer and infectious diseases, today announced that it will report 2023 financial results on Thursday, February 29, 2024, after the close of U.S. markets. Following the release, management will host a live conference call and webcast, including Q&A, at 4:30 p.m. ET to provide a corporate update and discuss financial results.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.